Ulcerative Colitis PBMC

In Stock Samples

Lot Number Condition Cell Count (M) Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
77473 Ulcerative Colitis 50M Caucasian African American Hispanic/Latino 21 Female
Birth Control QD
43 $1,109.00
77473 Ulcerative Colitis 50M Caucasian African American Hispanic/Latino 21 Female
Birth Control QD
1 $1,109.00
74068 Ulcerative Colitis 10M African American 40 Female
Sertraline 100 mg QD Topamax 50 mg QD Famotidine 10 mg QD Buspar 3.5 mg QD- no longer taking Remicade IV Q6W Crestor 5 mg QD Klonopin 0.5 mg PRN Hydroxyzine 25 mg PRN Zofran PRN
9 $530.00
72527 Ulcerative Colitis 10M African American 62 Male
Lisinopril 40 mg QD amlodipine 10mg QD atorvastatin 80mg QD fenofibrate 145 mg QD Cymbalta 60 mg QD metformin 1000 mg QD Entyvio 108 mg Q 2 weeks
8 $530.00
59240 Ulcerative Colitis 5M Caucasian 41 Female
Losartan 25 mg QD Lexapro 5 mg QD Xeljanz BID Nicotine Patch
1 $530.00
64425 Ulcerative Colitis 50M Caucasian 40 Male
Melatonin PRN Lialda 1.2 g 4pill 1x day
140 $1,109.00
77054 Ulcerative Colitis 50M Hispanic/Latino 47 Female
estradiol progesterone
107 $1,109.00
52147 Ulcerative Colitis 100M African American 48 Male
Azathioprine 50mg QD Modafinil 20mg QD Glimepiride 2mg QD Amlodipine 20mg QD
23
74062 Ulcerative Colitis 10M Caucasian 45 Male United States (US)
Lialda QD, Stelara Q4 weeks
7 $530.00
74064 Ulcerative Colitis 10M Caucasian 45 Female United States (US)
Rinvoq 15 mg once a day, Protonix 40mg QD Famotidine 40 mg BID Metronidazole cream- for rosacea - topical Ventolin Inhaler 2 puffs PRN Lexapro 10mg QD Ozempic 2mg injection QD for weight loss Adderall 40mg QD
5 $530.00

High-Quality Ulcerative Colitis PBMC for Research

Human Ulcerative Colitis PBMC products are sourced from donors clinically diagnosed with ulcerative colitis and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune cell phenotypes, gene expression, and responses to gut microbial antigens.

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed ulcerative colitis donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified ulcerative colitis diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Additional ulcerative colitis-specific data available upon request

Applications

  • Biomarker discovery and validation
  • Drug screening and therapeutic development
  • Immune pathway analysis in Ulcerative Colitis pathophysiology
  • Transcriptomic and proteomic profiling

Quality and Compliance

  • IRB-approved collections and protocols
  • 21 CFR Part 11 – compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Shipping

Ulcerative Colitis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Ulcerative Colitis Publications

PBMC

Frequently Asked Questions

Showing 1–12 of 30 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – with the exception of GMP leukopaks, all our products are research use only (RUO).

Our complete catalog can be found here: https://sanguinebio.com/products/

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information